Kara Kachurak

Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas

Gregory K. Friedman, James M. Johnston, Asim K. Bag et al. · New England Journal of Medicine · 2021 · 319 citations · Full text

Medicine, Immunology, Oncology +17

Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma

Tom Rosenberg, Kee Kiat Yeo, Audrey Mauguen et al. · Neuro-Oncology · 2022 · 63 citations · Full text

Medicine, Molecular Medicine, Oncology +11

Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors

Alicia M. Waters, James M. Johnston, Alyssa Reddy et al. · Human Gene Therapy Clinical Development · 2017 · 57 citations

Medicine, Oncology, Radiation Oncology +15

Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors

Joshua D. Bernstock, Asim K. Bag, John B. Fiveash et al. · Human Gene Therapy · 2020 · 36 citations · Full text

Medicine, Immunology, Oncology +17

A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibition

Joshua D. Bernstock, Nunzio Vicario, Rong Li et al. · OncoImmunology · 2019 · 33 citations · Full text

Medicine, Immunology, Oncology +17